Recently, Theruvath, J. et al. demonstrated that combination treatment of anti-GD2 and anti-CD47 has potent antitumor synergy by promoting macrophages to phagocytose tumor cells in neuroblastoma, osteosarcoma and small-cell lung cancer. Here, CD47 is linked to neoplasm.